This company listing is no longer active
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Laboratorio Reig Jofre Croissance future
Future contrôle des critères 4/6
Laboratorio Reig Jofre is forecasted to grow earnings and revenue by 26.6% and 5.5% per annum respectively. EPS is expected to grow by 26.4%. Return on equity is forecast to be 8.5% in 3 years.
Informations clés
26.6%
Taux de croissance des bénéfices
26.4%
Taux de croissance du BPA
Pharmaceuticals croissance des bénéfices | 15.4% |
Taux de croissance des recettes | 5.5% |
Rendement futur des capitaux propres | 8.5% |
Couverture par les analystes | Low |
Dernière mise à jour | n/a |
Mises à jour récentes de la croissance future
Pas de mise à jour
Recent updates
Pas de mise à jour
Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2024 | 291 | 14 | 17 | 35 | 1 |
12/31/2023 | 279 | 12 | 14 | 31 | 1 |
12/31/2022 | 261 | 7 | 4 | 19 | 1 |
12/31/2021 | 240 | 5 | -5 | 14 | N/A |
9/30/2021 | 237 | 6 | N/A | N/A | N/A |
6/30/2021 | 234 | 6 | 9 | 26 | N/A |
3/31/2021 | 234 | 6 | N/A | N/A | N/A |
12/31/2020 | 234 | 6 | 7 | 19 | N/A |
9/30/2020 | 229 | 8 | N/A | N/A | N/A |
6/30/2020 | 229 | 6 | -15 | 14 | N/A |
3/31/2020 | 219 | 6 | N/A | N/A | N/A |
12/31/2019 | 206 | 5 | -19 | 12 | N/A |
9/30/2019 | 199 | 7 | N/A | N/A | N/A |
6/30/2019 | 188 | 9 | -10 | 16 | N/A |
3/31/2019 | 188 | 9 | N/A | N/A | N/A |
12/31/2018 | 185 | 9 | -6 | 15 | N/A |
9/30/2018 | 185 | 10 | N/A | N/A | N/A |
6/30/2018 | 179 | 9 | -4 | 14 | N/A |
3/31/2018 | 175 | 9 | N/A | N/A | N/A |
12/31/2017 | 172 | 9 | 3 | 21 | N/A |
9/30/2017 | 164 | 5 | N/A | N/A | N/A |
6/30/2017 | 164 | 7 | -6 | 8 | N/A |
3/31/2017 | 164 | 8 | N/A | N/A | N/A |
12/31/2016 | 161 | 8 | -14 | -1 | N/A |
9/30/2016 | 160 | 5 | N/A | N/A | N/A |
6/30/2016 | 159 | 5 | -4 | 8 | N/A |
3/31/2016 | 156 | 5 | N/A | N/A | N/A |
12/31/2015 | 157 | 9 | 2 | 13 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: RJF.D's forecast earnings growth (26.6% per year) is above the savings rate (0.9%).
Bénéfices vs marché: RJF.D's earnings (26.6% per year) are forecast to grow faster than the Spanish market (10.3% per year).
Croissance élevée des bénéfices: RJF.D's earnings are expected to grow significantly over the next 3 years.
Chiffre d'affaires vs marché: RJF.D's revenue (5.5% per year) is forecast to grow faster than the Spanish market (3% per year).
Croissance élevée des revenus: RJF.D's revenue (5.5% per year) is forecast to grow slower than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: RJF.D's Return on Equity is forecast to be low in 3 years time (8.5%).